Altogether, these observations led us to conclude that our inability to observe a significant impact of clathrin inhibition on AKT phosphorylation upon addition of EGF reflects the fact that all HCC cell lines studied expressed ErbB2. The gene discussed is ERBB2; the disease is hepatocellular carcinoma.